Ally Bridge Group Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
17
- Investments
-
100
- Portfolio
-
43
- Exits
-
41
Ally Bridge Group General Information
Description
Founded in 2013, Ally Bridge Group is a private equity investment firm based in Hong Kong. The firm prefers to invest through means of buyouts, growth capital and venture capital investments. The firm prefers to invest in the healthcare and life sciences sectors.
Contact Information
Website
www.ally-bridge.com
Year Founded
2013
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Growth/Expansion
Hedge Fund
Venture Capital
Primary Office
- 30th Floor, Gloucester Tower, The Landmark
- 15 Queen's Road Central
- Hong Kong
- Hong Kong
+852 3121 0000
Ally Bridge Group Investments (100)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 000000000 | 14-Apr-2023 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | |
| 00000 000000000000 | 18-Jan-2023 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 1 | |
| 00 00000000 | 01-Oct-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 3 | 000000 0000 |
| 00000000 | 16-Sep-2022 | 00000 00000 | 00000 | Diagnostic Equipment | Generating Revenue | 0000000 0000 |
| Syros Pharmaceuticals | 16-Sep-2022 | PIPE | 00000 | Drug Discovery | Generating Revenue |
Ally Bridge Group Exits (41)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 000000000 000 | 27-Jan-2023 | 000 00 00000000 | |
| 00000000 000000000 | 16-Jun-2022 | 000000000 00000000 | |
| 00000000 | 26-Apr-2022 | 000000000000000000 | 000.00 |
| 00000000 | 02-Dec-2021 | 000000000000000000 | |
| Sonendo | 29-Oct-2021 | IPO | 000.00 |
Ally Bridge Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Ally Bridge Group Team (40)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Frank Yu | Co-Founder, Chief Investment Officer & Chief Executive Officer | 00 | 0 | 0 | Hong Kong, Hong Kong |
| Charles Wong | Chief Financial Officer | Hong Kong, Hong Kong | |||
| Kevin Corb | Chief Financial Officer, Public Equity | New York, NY | |||
| Michael Bendetson JD | Chief Operating Officer, Head of Legal & Chief Compliance Officer | New York, NY | |||
| Andrew Pang | Managing Director | 0 | Hong Kong, Hong Kong |